Table 1. Compounds 11 and 13 Display Enhanced Antibacterial Activity against S. aureus and S. epidermidis.

		minimum inhibitory concentration (μg/mL)
strain	1771	9	10	11	12	13	14
S. aureus
LAC	8	32–64	64	4	8	0.5	>64
MW2	8	64	64	2	8	0.5	>64
Newman	4–8	32	64	2	8	0.5	>64
SH1000	4–8	32	64	2	8	0.5	>64
MRSA252	8	64	64	4	16	1	>64
TW20	8	32	64	2	8	0.5	>64
Mu50	4–8	64	64	2	4–8	0.5	>64
Mu3	8–16	64	64	2	8	0.5	>64
EMRSA-15	8–16	64	32–64	2	8	0.5	>64
S. epidermidis
RP62A	8–16	32	64	2–4	4–8	0.5	>64
311	8–16	64	32–64	2	4–8	0.5	>64
771	8–16	64	32–64	2	4–8	0.5	>64
780	8–16	32	32–64	4	4–8	0.5–1	>64
319	8–16	64	64	2	4–8	1	>64
322	16	64	64	4	8	0.5	>64
305	8–16	64	32–64	2–4	8	0.5–1	>64